https://www.marketscreener.com/quote/stock/ALZAMEND-NEURO-INC-123731313/news/Alzamend-Neuro-Receives-Positive-Pre-IND-Response-from-FDA-for-AL002-a-Cell-Based-Therapeutic-Vac-36561435/?utm_source=telegram&utm_medium=social&utm_campaign=share